Nurse Practitioner, Family · Johnson City, NY
NPI
1306277017
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
30 Harrison St, Suite 100
Johnson City, NY, 13790
Phone (607) 763-6850
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
349 services
Medicare patients, 2024
130
Average age 74
Drug cost, 2024
$5.5M
1,969 prescriptions
Company payments, 2025
$3,771
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kara Spalik was code 99214 (office e&m - established), 311 times for 119 patients. In total Kara Spalik billed 349 services in 3 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 311 | 119 | $58.75 | $18K |
| 99213 Office E&M - Established | Facility | 27 | 18 | $41.52 | $1,121 |
By year: 2022 $29K for 507 services; 2023 $24K for 408 services; 2024 $20K for 349 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kara Spalik prescribed most often to Medicare patients was Ondansetron Hcl, with 113 prescriptions and refills. In total Kara Spalik wrote 1,969 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 113 | 113 | 59 | $972 |
| Oxycodone Hcl Generic | 84 | 84 | 34 | $1,907 |
| Anastrozole Generic | 83 | 218 | 36 | $1,952 |
| Prochlorperazine Maleate Generic | 79 | 79 | 49 | $1,010 |
| Eliquis Apixaban | 70 | 140 | 31 | $77K |
| Prednisone Generic | 63 | 75 | 28 | $326 |
| Gabapentin Generic | 52 | 77 | 24 | $582 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 52 | 52 | 11 | $2,835 |
| Jakafi Ruxolitinib Phosphate | 51 | 51 | Under 11 | $780K |
| Dexamethasone Generic | 48 | 64 | 25 | $981 |
| Lenalidomide Generic | 48 | 48 | 15 | $626K |
| Potassium Chloride Generic | 46 | 69 | 25 | $738 |
| Famotidine Generic | 38 | 81 | 16 | $431 |
| Lorazepam Generic | 37 | 37 | 22 | $208 |
| Acyclovir Generic | 36 | 70 | 12 | $633 |
Brand drugs: - claims; generic drugs: 1,538 claims; opioid claims: 220.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kara Spalik $3,771 ($3,771 in general payments such as food, travel and fees) from 42 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $363.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $363 |
| Abbvie Inc. ABBV | 14 | $318 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $261 |
| Daiichi Sankyo Inc. 4568.T | 12 | $224 |
| Gilead Sciences, Inc. GILD | 5 | $211 |
| Pfizer Inc. PFE | 14 | $202 |
| Eisai Inc. 4523.T | 8 | $180 |
| Merck Sharp & Dohme LLC MRK | 9 | $150 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $145 |
| Immunocore Limited IMCR | 1 | $143 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.